Identification of New Biomarkers for the Prediction of Cardiovascular Events

Recruiting now

Conditions studied: Cardiovascular Diseases

In brief

The main goal of this project is to constitute a collection of biological samples, obtained through the clinical activity of the Centre for Screening and Prevention of Atherosclerosis at Toulouse University Hospital, managing patients in primary or secondary prevention for cardiovascular (CV) diseases. The main objective is to validate new biomarkers with prognostic value regarding the onset of future CV events. Besides, the biological collection will enable patho-physiological studies on atherosclerosis related diseases.

Key facts

Study ID

NCT04809506

Run by

University Hospital, Toulouse

People needed

1500

Starts

2021-02-04

Expected to finish

2034-02-03

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults over 18 yrs;
• consulting the Centre for Screening and Prevention of Atherosclerosis (CDPA) for management of their cardiovascular risk factors;
• patients on primary prevention, free of personal history of coronary artery disease, stroke or lower limb arteriopathy, or patients on secondary prevention having presented one of the above mentioned diseases;
• patients affiliated to a health insurance system;
• patients having given their written informed consent for a participation to the study and for possible genetic analysis of their personal traits.

You may not qualify if…

• Patients under the age of 18;
• patients being under legal protection

Where it is running

• University Hospital Toulouse — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.